chr6-32044177-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_001365276.2(TNXB):​c.11264-48A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 656 hom., cov: 18)
Exomes 𝑓: 0.093 ( 23017 hom. )
Failed GnomAD Quality Control

Consequence

TNXB
NM_001365276.2 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.07

Publications

1 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 6-32044177-T-C is Benign according to our data. Variant chr6-32044177-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261105.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001365276.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNXB
NM_001365276.2
MANE Select
c.11264-48A>G
intron
N/ANP_001352205.1
TNXB
NM_001428335.1
c.12005-48A>G
intron
N/ANP_001415264.1
TNXB
NM_019105.8
c.11258-48A>G
intron
N/ANP_061978.6

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNXB
ENST00000644971.2
MANE Select
c.11264-48A>G
intron
N/AENSP00000496448.1
TNXB
ENST00000451343.4
TSL:1
c.551-48A>G
intron
N/AENSP00000407685.1
TNXB
ENST00000490077.5
TSL:1
n.1091-48A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.110
AC:
10082
AN:
91794
Hom.:
654
Cov.:
18
show subpopulations
Gnomad AFR
AF:
0.0952
Gnomad AMI
AF:
0.0935
Gnomad AMR
AF:
0.131
Gnomad ASJ
AF:
0.110
Gnomad EAS
AF:
0.165
Gnomad SAS
AF:
0.173
Gnomad FIN
AF:
0.136
Gnomad MID
AF:
0.201
Gnomad NFE
AF:
0.101
Gnomad OTH
AF:
0.0920
GnomAD2 exomes
AF:
0.0151
AC:
2728
AN:
180354
AF XY:
0.0147
show subpopulations
Gnomad AFR exome
AF:
0.00468
Gnomad AMR exome
AF:
0.0104
Gnomad ASJ exome
AF:
0.0146
Gnomad EAS exome
AF:
0.0585
Gnomad FIN exome
AF:
0.00625
Gnomad NFE exome
AF:
0.00577
Gnomad OTH exome
AF:
0.0162
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0931
AC:
99289
AN:
1066198
Hom.:
23017
Cov.:
31
AF XY:
0.0984
AC XY:
52088
AN XY:
529618
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.118
AC:
2836
AN:
23980
American (AMR)
AF:
0.183
AC:
5326
AN:
29174
Ashkenazi Jewish (ASJ)
AF:
0.166
AC:
3313
AN:
19962
East Asian (EAS)
AF:
0.245
AC:
7169
AN:
29310
South Asian (SAS)
AF:
0.195
AC:
11278
AN:
57722
European-Finnish (FIN)
AF:
0.188
AC:
7246
AN:
38618
Middle Eastern (MID)
AF:
0.162
AC:
536
AN:
3304
European-Non Finnish (NFE)
AF:
0.0680
AC:
55815
AN:
820234
Other (OTH)
AF:
0.131
AC:
5770
AN:
43894
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.301
Heterozygous variant carriers
0
5396
10793
16189
21586
26982
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.110
AC:
10085
AN:
91830
Hom.:
656
Cov.:
18
AF XY:
0.108
AC XY:
4792
AN XY:
44482
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0953
AC:
2249
AN:
23588
American (AMR)
AF:
0.131
AC:
1239
AN:
9428
Ashkenazi Jewish (ASJ)
AF:
0.110
AC:
250
AN:
2268
East Asian (EAS)
AF:
0.164
AC:
539
AN:
3290
South Asian (SAS)
AF:
0.172
AC:
459
AN:
2670
European-Finnish (FIN)
AF:
0.136
AC:
822
AN:
6048
Middle Eastern (MID)
AF:
0.210
AC:
44
AN:
210
European-Non Finnish (NFE)
AF:
0.101
AC:
4317
AN:
42580
Other (OTH)
AF:
0.0955
AC:
123
AN:
1288
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.295
Heterozygous variant carriers
0
752
1504
2257
3009
3761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0601
Hom.:
209

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
9.9
DANN
Benign
0.35
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2856450; hg19: chr6-32011954; COSMIC: COSV107499830; COSMIC: COSV107499830; API